首页> 外文期刊>World Journal of Gastroenterology >Hepatoma with cardiac metastasis: An advanced cancer requiring advanced treatment
【24h】

Hepatoma with cardiac metastasis: An advanced cancer requiring advanced treatment

机译:肝癌合并心脏转移:需要晚期治疗的晚期癌症

获取原文
获取原文并翻译 | 示例
           

摘要

AIM: To investigate the clinical and pathologic findings, and to discuss the pathophysiology of hepatocellular carcinoma with cardiac metastasis. METHODS: Eight hepatoma patients with cardiac metastasis, who were treated by surgical excision from 1993 to 2006, were retrospectively studied. Detailed clinical parameters were analyzed. RESULTS: Of those eight patients, two (25%) were women and six (75%) were men, with the mean age of 50 years (range, 40-70 years). The presentations included: asymptomatic (75%), heart failure (25%), and pulmonary embolism (12.5%). All lesions involved the right atrium, and extended to the lung (12.5%), inferior vena cava (25%), and left atrium (12.5%). The level of tumor marker, alpha-fetal protein, was not correlated with the severity of metastasis or disease prognosis. Moreover, the availably estimated doubling time was less than 3 mo. The pathological findings included variable hemorrhage and necrosis. The survival time following surgery also varied from one month to more than 30 mo. CONCLUSION: Hepatoma metastasis to the heart was detected in all eight patients. This study demonstrates that surgery might help the outcome in such cases.
机译:目的:探讨临床和病理结果,并探讨伴有心脏转移的肝细胞癌的病理生理学。方法:回顾性分析1993年至2006年经手术切除的8例心脏转移性肝癌患者的临床资料。详细的临床参数进行了分析。结果:在这八名患者中,两名(25%)为女性,六名(75%)为男性,平均年龄为50岁(范围40-70岁)。报告包括:无症状(75%),心力衰竭(25%)和肺栓塞(12.5%)。所有病变均累及右心房,并延伸至肺(12.5%),下腔静脉(25%)和左心房(12.5%)。肿瘤标志物α-胎儿蛋白的水平与转移的严重程度或疾病预后无关。此外,可用的估计倍增时间少于3 mo。病理结果包括可变性出血和坏死。手术后的生存时间也从一个月到超过30个月不等。结论:所有八例患者均检测到肝癌转移至心脏。这项研究表明,在这种情况下手术可能有助于结果。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号